3α-[(5S,6S,7R)-5-Ethyl-1,2,3,4,5,6,7,8,9,10-decahydro-6-hydroxy-3,7-methanoazacycloundecino[5,4-b]indol-12-yl]vobasan-17-oic acid methyl ester (57533-88-7)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 2H-3,7-Methanoazacycloundecino[5,4-b]indole- 9-carboxylic acid,9-[(2â,3â,5R,12â,19R)-3'- (2-chloroethyl)-6,7-didehydro-1-formyl-16- methoxy-2',4'-dioxospiro[aspidospermidine-3,- 5'-oxazolidin]-15-yl]-5-ethyl-1,4,5,6,7,8,9,- 10-octahydro-5-hydroxy-,methyl ester,(3R,5S,7R,9S)-
- methyl (2beta,3beta,4beta,5alpha,12beta,19xi)-4-(acetyloxy)-15-[(5S,6S,8S)-5-ethyl-6-hydroxy-8-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carb
- Vobasan-17-oic acid,3-[(2S,4E,5R)-4-ethylidene- 1,3,4,5,6,7-hexahydro-6-methylene-2,5- ethano-2H-azocino[4,3-b]indol-10-yl]-,methyl ester,(3R)-
- 4-[({[2-({(2beta,3beta,4beta,5alpha,19alpha)-15-[(5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methanoazacycloundecino[5,4-b]indol-9-yl]-3,4-dihydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidin-3-yl}carbonyl)hydr
- Vobasan-17-oic acid,3-[3-(2-aminoethyl)-1H-indol-6-yl]-, methyl ester, (3a)- (9CI)
- 2H-3,7-Methanoazacycloundecino[5,4-b]indol-6-ol,5-ethyl-1,4,5,6,7,8,9,10-octahydro-, (5S,6S,7R)- (9CI)
- Vobasan-17-oic acid,3-[(3R)-17-hydroxy-1- methylsarpagan-10-yl]-,methyl ester
- Propanoic acid,2-methyl-,(3aS,4R,5S,6S,7R,- 7aS)-6-ethenyloctahydro-4-hydroxy-5-[1- (hydroxymethyl)ethenyl]-6-methyl-3-methylene- 2-oxo-7-benzofuranyl ester
- 5-Isoquinolinecarboxylicacid,7-(acetyloxy)decahydro-6-methoxy-2-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3-oxo-,methyl ester, (4aS,5S,6R,7R,8aS)-
- 5,12-Naphthacenedione,8-ethyl-7,8,9,10-tetrahydro- 1,6,8,11-tetrahydroxy-10-[[2,3,6- trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)- tetrahydro-6-methyl-5-oxo-2H-pyran-2- yl]-R-L-lyxo-hexopyranosyl]-3-(dimethylamino)- R-L-lyxo-hexopyranosyl]oxy]-7-[[2,3,- 6-trideoxy-3-(dimethylamino)-4-O-[(2S,5S,- 6S)-tetrahydro-6-methyl-5-[[(2S,5S,6S)- tetrahydro-5-hydroxy-6-methyl-2H-pyran- 2-yl]oxy]-2H-pyran-2-yl]-R-L-lyxohexopyranosyl] oxy]-,(7R,8R,10S)-
- 1/C14H16O4/c1-5-10-12-9(14(15)18-10)6-7-11(16-4)13(12)17-8(2)3/h5-8,10H,1H2,2-4H
- 1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
- 1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
- 1/C12H11NO4/c1-6-10(15)7-3-4-13-8(5-14)9(7)11(16)12(6)17-2/h3-4,14H,5H2,1-2H
- Vobasan-17-oic acid,3-[[(4E,5R,6Z)-4-ethylidene- 1,4,5,7-tetrahydro-2,5-ethano-2Hazocino[ 4,3-b]indol-6(3H)-ylidene]methyl]-,methyl ester,(3R)-
- 1/C11H9N5O/c1-17-6-2-3-8-9(4-6)16-11(14-8)7(5-12)10(13)15-16/h2-4,14H,1H3,(H2,13,15
- 1/C14H19NO2/c1-3-12-10-17-9-8-15(12)14-7-5-4-6-13(14)11(2)16/h4-7,12H,3,8-10H2,1-2H
- 1/C15H18O2/c1-11(16)6-7-12-4-3-5-13-10-14(17-2)8-9-15(12)13/h4,8-10H,3,5-7H2,1-2H
- 3-Methyl-2-butenoic acid [(1aR,4E,6R,7R,7aR,10aS,10bR)-1a,2,3,6,7,7a,8,9,10a,10b-decahydro-6-hydroxy-1a,5-dimethyl-8-methylene-9-oxooxireno[9,10]cyclodeca[1,2-b]furan-7-yl] ester
- Benzoic acid,6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methyl-,sodium salt (1:1)